p53 is often inactivated in cancers by different strategies, namely by interactions with murine double minute (MDM) proteins, MDM2 and MDMX, which are commonly overexpressed in cancers or by missense mutations, leading to loss of its wild-type (wt) tumor suppressor function [6]. This evidence concerns the gene TP53 and cancer.